Katlyn Nemani, M.D.

Dr. Katlyn Nemani is a clinical research psychiatrist at the Nathan Kline Institute and Research Assistant Professor of Psychiatry at the New York University School of Medicine. After earning her medical degree at Tufts University, she completed combined residency training in neurology and psychiatry at the NYU. Her goal is to advance and improve care for people with disorders at the interface of psychiatry and neurology with a cross-disciplinary approach. Prior to joining the Nathan Kline Institute she conducted clinical research at the Montreal Neurological Institute, Schizophrenia Research Program at Massachusetts General Hospital, and at NYU with mentorship from Dr. Donald Goff. Her research is focused on understanding the bidirectional relationship between systemic disease and psychopathology, particularly the interaction between the nervous system and immune system in people with psychosis.

During the COVID-19 pandemic Dr. Nemani completed several studies establishing schizophrenia as an independent risk factor for mortality among patients with COVID-19 infection. She is currently building upon this research to identify immune alterations in individuals with schizophrenia which may contribute to susceptibility to severe infection and symptoms of psychosis. Her current work is focused on examining immune responses to vaccination and autoantibody profiles in people with schizophrenia.